SEC Form 4 · accession 0001140361-17-016070
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hollingshead
Officer — President, Americas
Period of report
Apr 17, 2017
Accepted (ET)
Apr 18, 2017 · 2:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Apr 17, 2017 | M | 5,264 | $43.63 | A | 44,934 | D | |
| ResMed Common Stock | Apr 17, 2017 | S | 5,264 | $68.37 | D | 39,670 | D | |
| ResMed Common Stock | Apr 17, 2017 | S | 1,875 | $68.37 | D | 37,795 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $43.63 | Apr 17, 2017 | M | 5,264 | D | Mar 1, 2014 | Mar 1, 2020 | ResMed Common Stock | 5,264 | 12,284 | D |
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 Plan.
- F2Represents date options first became exercisable. Options vest ? per year.